Trevena Settles Opioid Substitute Stock-Drop Suit For $8.5M
A Pennsylvania federal court has given its final approval to an $8.5 million settlement between Trevena Inc. and investors who say the biopharmaceutical company misled them about federal approvals for a...To view the full article, register now.
Already a subscriber? Click here to view full article